About Hetero Labs Limited
Data last updated: 25 February 2026
Hetero Labs Limited is a public limited company based in Balanagar, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 10 March 1989, the company has been in operation for over 37 years.
Registered with ROC Hyderabad under CIN U24110TG1989PLC009723.
Capital: an authorised share capital of ₹320 Cr and a paid-up capital of ₹277.06 Cr. Formerly known as Permila Drugs Private Limited and Hetero Drugs Private Limited. It is led by directors including Bandi Vamsikrishna and Govindaraju Bhavani.
Last AGM: 11 September 2025. Financial statements filed for year ended 31 March 2025. Office: Balanagar, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹16,537 Cr, a growth of 13% compared to the previous year.
The company has a workforce of approximately 7,319 employees as per the latest available data. Its group structure includes 14 subsidiaries.
The company is associated with 1 brand - Hetero. As per MCA filings, the company has open charges of ₹6,736.19 Cr and satisfied charges of ₹13,851 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hetero.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address#7 – 2 – A2, Industrial Estate Sanath Nagar, Balanagar, Telangana, India – 500018
-
IndustryPharma, Drug Formulation & Development, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Hetero Labs Limited
Hetero Labs Limited has undergone 3 name changes throughout its history. The company was previously known as Permila Drugs Private Limited, Hetero Drugs Private Limited, and Pharmasia Laboratory Private Limited. The current legal name is Hetero Labs Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Hetero Labs Limited | Current |
| Permila Drugs Private Limited | Previous |
| Hetero Drugs Private Limited | Previous |
| Pharmasia Laboratory Private Limited | Previous |
CIN History of Hetero Labs Limited
Hetero Labs Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24110TG1989PLC009723, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110TG1989PLC009723 | Current |
| U24110AP1989PLC009723 | Previous |
| L24110AP1989PLC009723 | Previous |
Associated Brands with Hetero Labs Limited
Hetero Labs Limited operates one associated brand: Hetero. These brands represent Hetero Labs Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Hetero is recognized as a leading global pharmaceutical company based in India. | hetero.com |
Competitors & Alternatives of Hetero Labs Limited
Brands and companies operating in the same space as Hetero Labs Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Merck
|
Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
Roivant Sciences
|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
AbbVie
|
Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
Lilly
|
Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
Gilead
|
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
United Therapeutics
|
Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
Roche
|
Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
Ascendis Pharma
|
Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
MorphoSys
|
Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
Vertex Pharmaceuticals
|
Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Hetero Labs Limited
Hetero Labs Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Hetero Labs Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Hetero Labs Limited
Hetero Labs Limited is audited by M.V.Narayana Reddy & Co. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.V.Narayana Reddy & Co. | Locked | Locked | Locked |
Complete auditor history for Hetero Labs Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Hetero Labs Limited
Hetero Labs Limited is currently managed by 7 directors, with 22 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of Hetero Labs Limited FY 2025 filings available
Hetero Labs Limited reported revenue of ₹16,537 Cr (up 13.00% YoY) for FY 2025.
Ten-year financial statements for Hetero Labs Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Hetero Labs Limited
Shareholding and ownership data for Hetero Labs Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Hetero Labs Limited
Hetero Labs Limited has 14 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Hetero Labs Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|
Showing major subsidiaries. Total: 14.
Charges & Borrowings of Hetero Labs Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2026 | Others | ₹30.22 Lakh | Open |
| 23 Jan 2026 | Others | ₹15.14 Lakh | Open |
| 31 Dec 2025 | Others | ₹9.8 Lakh | Open |
| 30 Dec 2025 | Others | ₹64 Lakh | Open |
| 20 Dec 2025 | Others | ₹20.16 Lakh | Open |
Total charge records: 169 View all charges
Employees and EPFO Compliance at Hetero Labs Limited
Hetero Labs Limited has a workforce of 7,319 employees as of Nov 20, 2024.
Employee and EPFO history for Hetero Labs Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Hetero Labs Limited
GST registrations and filing compliance for Hetero Labs Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Hetero Labs Limited
Credit ratings, litigation, and regulatory alerts for Hetero Labs Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hetero Labs Limited
MSME payment history for Hetero Labs Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hetero Labs Limited
Corporate group structure for Hetero Labs Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hetero Labs Limited
MCA filings and documents for Hetero Labs Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Hetero Labs Limited
Recent News on Hetero Labs Limited
Frequently Asked Questions about Hetero Labs Limited
Hetero Labs Limited is an active public limited company in the pharma sector based in Balanagar, Telangana, India. It was incorporated on 10 March 1989 (37+ years old) and is registered under CIN U24110TG1989PLC009723. The company has 7,319 employees.
Hetero Labs Limited reported revenue of ₹16,537 Cr for FY 2025 (up 13.00% YoY).
The current directors of Hetero Labs Limited are:
- Bandi Vamsikrishna - Managing Director
- Govindaraju Bhavani - Director
- Parthasaradhi Reddy Bandi - Director
- Srinivas Reddy Male - Director
- Attunuri Venkatanarasa Reddy - Whole-Time Director
- Sujesh Vasudevan - Director
- Mohana Reddy Chilukuri - Whole-Time Director
The primary industry of Hetero Labs Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Hetero Labs Limited can be reached at the registered office: #7 – 2 – A2, Industrial Estate Sanath Nagar, Balanagar, Telangana, India – 500018, or through the website hetero.com.
The authorised capital is ₹320 Cr, and the paid-up capital is ₹277.06 Cr.